ニタゾキサニド薬品のグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Nitazoxanide Drug Market Insights and Forecast to 2027

• レポートコード：QY2112C03897 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、88ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はニタゾキサニド薬品の世界市場の現状について調査・分析し、2027年までの市場を予測しました。ニタゾキサニド薬品の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（錠剤、経口懸濁液）、用途別市場規模（病院、小売薬局、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・ニタゾキサニド薬品の世界市場概要 ・メーカー別の競争状況、市場シェア ・ニタゾキサニド薬品の種類別市場規模：錠剤、経口懸濁液 ・ニタゾキサニド薬品の用途別市場規模：病院、小売薬局、その他 ・北米のニタゾキサニド薬品市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのニタゾキサニド薬品市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのニタゾキサニド薬品市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のニタゾキサニド薬品市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのニタゾキサニド薬品市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Romark Laboratories、Chugai Pharmaceutical、Lupin ・ニタゾキサニド薬品のバリューチェーン・販売チャネル分析 ・ニタゾキサニド薬品の世界市場動向

Nitazoxanide, sold under the brand name Alinia among others, Nitazoxanide is an antiprotozoal medicine that treats infections caused by protozoa (single-cell parasites that live in moist places such as lakes, streams, and soil).

Market Analysis and Insights: Global Nitazoxanide Drug Market
The global Nitazoxanide Drug market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Nitazoxanide Drug Scope and Segment
Nitazoxanide Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nitazoxanide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Tablets
Oral Suspension

Segment by Application
Hospital
Retail Pharmacy
Other

By Company
Romark Laboratories
Chugai Pharmaceutical
Lupin

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Nitazoxanide Drug Product Introduction
1.2 Market by Type
1.2.1 Global Nitazoxanide Drug Market Size Growth Rate by Type
1.2.2 Tablets
1.2.3 Oral Suspension
1.3 Market by Application
1.3.1 Global Nitazoxanide Drug Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Nitazoxanide Drug Sales Estimates and Forecasts 2016-2027
2.2 Global Nitazoxanide Drug Revenue Estimates and Forecasts 2016-2027
2.3 Global Nitazoxanide Drug Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Nitazoxanide Drug Regions by Sales
2.4.1 Global Top Nitazoxanide Drug Regions by Sales (2016-2021)
2.4.2 Global Top Nitazoxanide Drug Regions by Sales (2022-2027)
2.5 Global Top Nitazoxanide Drug Regions by Revenue
2.5.1 Global Top Nitazoxanide Drug Regions by Revenue (2016-2021)
2.5.2 Global Top Nitazoxanide Drug Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Nitazoxanide Drug Sales by Manufacturers
3.1.1 Global Top Nitazoxanide Drug Manufacturers by Sales (2016-2021)
3.1.2 Global Top Nitazoxanide Drug Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Nitazoxanide Drug Sales in 2020
3.2 Global Nitazoxanide Drug Revenue by Manufacturers
3.2.1 Global Top Nitazoxanide Drug Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Nitazoxanide Drug Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Nitazoxanide Drug Revenue in 2020
3.3 Global Nitazoxanide Drug Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nitazoxanide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nitazoxanide Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Nitazoxanide Drug Sales by Type
4.1.1 Global Nitazoxanide Drug Historical Sales by Type (2016-2021)
4.1.2 Global Nitazoxanide Drug Forecasted Sales by Type (2022-2027)
4.1.3 Global Nitazoxanide Drug Sales Market Share by Type (2016-2027)
4.2 Global Nitazoxanide Drug Revenue by Type
4.2.1 Global Nitazoxanide Drug Historical Revenue by Type (2016-2021)
4.2.2 Global Nitazoxanide Drug Forecasted Revenue by Type (2022-2027)
4.2.3 Global Nitazoxanide Drug Revenue Market Share by Type (2016-2027)
4.3 Global Nitazoxanide Drug Price by Type
4.3.1 Global Nitazoxanide Drug Price by Type (2016-2021)
4.3.2 Global Nitazoxanide Drug Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Nitazoxanide Drug Sales by Application
5.1.1 Global Nitazoxanide Drug Historical Sales by Application (2016-2021)
5.1.2 Global Nitazoxanide Drug Forecasted Sales by Application (2022-2027)
5.1.3 Global Nitazoxanide Drug Sales Market Share by Application (2016-2027)
5.2 Global Nitazoxanide Drug Revenue by Application
5.2.1 Global Nitazoxanide Drug Historical Revenue by Application (2016-2021)
5.2.2 Global Nitazoxanide Drug Forecasted Revenue by Application (2022-2027)
5.2.3 Global Nitazoxanide Drug Revenue Market Share by Application (2016-2027)
5.3 Global Nitazoxanide Drug Price by Application
5.3.1 Global Nitazoxanide Drug Price by Application (2016-2021)
5.3.2 Global Nitazoxanide Drug Price Forecast by Application (2022-2027)

6 North America
6.1 North America Nitazoxanide Drug Market Size by Type
6.1.1 North America Nitazoxanide Drug Sales by Type (2016-2027)
6.1.2 North America Nitazoxanide Drug Revenue by Type (2016-2027)
6.2 North America Nitazoxanide Drug Market Size by Application
6.2.1 North America Nitazoxanide Drug Sales by Application (2016-2027)
6.2.2 North America Nitazoxanide Drug Revenue by Application (2016-2027)
6.3 North America Nitazoxanide Drug Market Size by Country
6.3.1 North America Nitazoxanide Drug Sales by Country (2016-2027)
6.3.2 North America Nitazoxanide Drug Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Nitazoxanide Drug Market Size by Type
7.1.1 Europe Nitazoxanide Drug Sales by Type (2016-2027)
7.1.2 Europe Nitazoxanide Drug Revenue by Type (2016-2027)
7.2 Europe Nitazoxanide Drug Market Size by Application
7.2.1 Europe Nitazoxanide Drug Sales by Application (2016-2027)
7.2.2 Europe Nitazoxanide Drug Revenue by Application (2016-2027)
7.3 Europe Nitazoxanide Drug Market Size by Country
7.3.1 Europe Nitazoxanide Drug Sales by Country (2016-2027)
7.3.2 Europe Nitazoxanide Drug Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Nitazoxanide Drug Market Size by Type
8.1.1 Asia Pacific Nitazoxanide Drug Sales by Type (2016-2027)
8.1.2 Asia Pacific Nitazoxanide Drug Revenue by Type (2016-2027)
8.2 Asia Pacific Nitazoxanide Drug Market Size by Application
8.2.1 Asia Pacific Nitazoxanide Drug Sales by Application (2016-2027)
8.2.2 Asia Pacific Nitazoxanide Drug Revenue by Application (2016-2027)
8.3 Asia Pacific Nitazoxanide Drug Market Size by Region
8.3.1 Asia Pacific Nitazoxanide Drug Sales by Region (2016-2027)
8.3.2 Asia Pacific Nitazoxanide Drug Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Nitazoxanide Drug Market Size by Type
9.1.1 Latin America Nitazoxanide Drug Sales by Type (2016-2027)
9.1.2 Latin America Nitazoxanide Drug Revenue by Type (2016-2027)
9.2 Latin America Nitazoxanide Drug Market Size by Application
9.2.1 Latin America Nitazoxanide Drug Sales by Application (2016-2027)
9.2.2 Latin America Nitazoxanide Drug Revenue by Application (2016-2027)
9.3 Latin America Nitazoxanide Drug Market Size by Country
9.3.1 Latin America Nitazoxanide Drug Sales by Country (2016-2027)
9.3.2 Latin America Nitazoxanide Drug Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Nitazoxanide Drug Market Size by Type
10.1.1 Middle East and Africa Nitazoxanide Drug Sales by Type (2016-2027)
10.1.2 Middle East and Africa Nitazoxanide Drug Revenue by Type (2016-2027)
10.2 Middle East and Africa Nitazoxanide Drug Market Size by Application
10.2.1 Middle East and Africa Nitazoxanide Drug Sales by Application (2016-2027)
10.2.2 Middle East and Africa Nitazoxanide Drug Revenue by Application (2016-2027)
10.3 Middle East and Africa Nitazoxanide Drug Market Size by Country
10.3.1 Middle East and Africa Nitazoxanide Drug Sales by Country (2016-2027)
10.3.2 Middle East and Africa Nitazoxanide Drug Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Romark Laboratories
11.1.1 Romark Laboratories Corporation Information
11.1.2 Romark Laboratories Overview
11.1.3 Romark Laboratories Nitazoxanide Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Romark Laboratories Nitazoxanide Drug Product Description
11.1.5 Romark Laboratories Recent Developments
11.2 Chugai Pharmaceutical
11.2.1 Chugai Pharmaceutical Corporation Information
11.2.2 Chugai Pharmaceutical Overview
11.2.3 Chugai Pharmaceutical Nitazoxanide Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Chugai Pharmaceutical Nitazoxanide Drug Product Description
11.2.5 Chugai Pharmaceutical Recent Developments
11.3 Lupin
11.3.1 Lupin Corporation Information
11.3.2 Lupin Overview
11.3.3 Lupin Nitazoxanide Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Lupin Nitazoxanide Drug Product Description
11.3.5 Lupin Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Nitazoxanide Drug Value Chain Analysis
12.2 Nitazoxanide Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nitazoxanide Drug Production Mode & Process
12.4 Nitazoxanide Drug Sales and Marketing
12.4.1 Nitazoxanide Drug Sales Channels
12.4.2 Nitazoxanide Drug Distributors
12.5 Nitazoxanide Drug Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nitazoxanide Drug Industry Trends
13.2 Nitazoxanide Drug Market Drivers
13.3 Nitazoxanide Drug Market Challenges
13.4 Nitazoxanide Drug Market Restraints

14 Key Findings in The Global Nitazoxanide Drug Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Nitazoxanide Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Oral Suspension
Table 4. Global Nitazoxanide Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Nitazoxanide Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Nitazoxanide Drug Sales by Region (2016-2021) & (K Units)
Table 7. Global Nitazoxanide Drug Sales Market Share by Region (2016-2021)
Table 8. Global Nitazoxanide Drug Sales by Region (2022-2027) & (K Units)
Table 9. Global Nitazoxanide Drug Sales Market Share by Region (2022-2027)
Table 10. Global Nitazoxanide Drug Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Nitazoxanide Drug Revenue Market Share by Region (2016-2021)
Table 12. Global Nitazoxanide Drug Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Nitazoxanide Drug Revenue Market Share by Region (2022-2027)
Table 14. Global Nitazoxanide Drug Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Nitazoxanide Drug Sales Share by Manufacturers (2016-2021)
Table 16. Global Nitazoxanide Drug Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Nitazoxanide Drug Revenue Share by Manufacturers (2016-2021)
Table 18. Nitazoxanide Drug Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Nitazoxanide Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Nitazoxanide Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitazoxanide Drug as of 2020)
Table 21. Nitazoxanide Drug Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Nitazoxanide Drug Product Offered
Table 23. Date of Manufacturers Enter into Nitazoxanide Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Nitazoxanide Drug Sales by Type (2016-2021) & (K Units)
Table 26. Global Nitazoxanide Drug Sales by Type (2022-2027) & (K Units)
Table 27. Global Nitazoxanide Drug Sales Share by Type (2016-2021)
Table 28. Global Nitazoxanide Drug Sales Share by Type (2022-2027)
Table 29. Global Nitazoxanide Drug Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Nitazoxanide Drug Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Nitazoxanide Drug Revenue Share by Type (2016-2021)
Table 32. Global Nitazoxanide Drug Revenue Share by Type (2022-2027)
Table 33. Nitazoxanide Drug Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Nitazoxanide Drug Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Nitazoxanide Drug Sales by Application (2016-2021) & (K Units)
Table 36. Global Nitazoxanide Drug Sales by Application (2022-2027) & (K Units)
Table 37. Global Nitazoxanide Drug Sales Share by Application (2016-2021)
Table 38. Global Nitazoxanide Drug Sales Share by Application (2022-2027)
Table 39. Global Nitazoxanide Drug Revenue by Application (2016-2021) & (US$ Million)
Table 40. Global Nitazoxanide Drug Revenue by Application (2022-2027) & (US$ Million)
Table 41. Global Nitazoxanide Drug Revenue Share by Application (2016-2021)
Table 42. Global Nitazoxanide Drug Revenue Share by Application (2022-2027)
Table 43. Nitazoxanide Drug Price by Application (2016-2021) & (US$/Unit)
Table 44. Global Nitazoxanide Drug Price Forecast by Application (2022-2027) & (US$/Unit)
Table 45. North America Nitazoxanide Drug Sales by Type (2016-2021) & (K Units)
Table 46. North America Nitazoxanide Drug Sales by Type (2022-2027) & (K Units)
Table 47. North America Nitazoxanide Drug Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Nitazoxanide Drug Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Nitazoxanide Drug Sales by Application (2016-2021) & (K Units)
Table 50. North America Nitazoxanide Drug Sales by Application (2022-2027) & (K Units)
Table 51. North America Nitazoxanide Drug Revenue by Application (2016-2021) & (US$ Million)
Table 52. North America Nitazoxanide Drug Revenue by Application (2022-2027) & (US$ Million)
Table 53. North America Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 54. North America Nitazoxanide Drug Sales by Country (2022-2027) & (K Units)
Table 55. North America Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Nitazoxanide Drug Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Nitazoxanide Drug Sales by Type (2016-2021) & (K Units)
Table 58. Europe Nitazoxanide Drug Sales by Type (2022-2027) & (K Units)
Table 59. Europe Nitazoxanide Drug Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Nitazoxanide Drug Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Nitazoxanide Drug Sales by Application (2016-2021) & (K Units)
Table 62. Europe Nitazoxanide Drug Sales by Application (2022-2027) & (K Units)
Table 63. Europe Nitazoxanide Drug Revenue by Application (2016-2021) & (US$ Million)
Table 64. Europe Nitazoxanide Drug Revenue by Application (2022-2027) & (US$ Million)
Table 65. Europe Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 66. Europe Nitazoxanide Drug Sales by Country (2022-2027) & (K Units)
Table 67. Europe Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Nitazoxanide Drug Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Nitazoxanide Drug Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Nitazoxanide Drug Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Nitazoxanide Drug Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Nitazoxanide Drug Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Nitazoxanide Drug Sales by Application (2016-2021) & (K Units)
Table 74. Asia Pacific Nitazoxanide Drug Sales by Application (2022-2027) & (K Units)
Table 75. Asia Pacific Nitazoxanide Drug Revenue by Application (2016-2021) & (US$ Million)
Table 76. Asia Pacific Nitazoxanide Drug Revenue by Application (2022-2027) & (US$ Million)
Table 77. Asia Pacific Nitazoxanide Drug Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Nitazoxanide Drug Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Nitazoxanide Drug Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Nitazoxanide Drug Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Nitazoxanide Drug Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Nitazoxanide Drug Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Nitazoxanide Drug Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Nitazoxanide Drug Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Nitazoxanide Drug Sales by Application (2016-2021) & (K Units)
Table 86. Latin America Nitazoxanide Drug Sales by Application (2022-2027) & (K Units)
Table 87. Latin America Nitazoxanide Drug Revenue by Application (2016-2021) & (US$ Million)
Table 88. Latin America Nitazoxanide Drug Revenue by Application (2022-2027) & (US$ Million)
Table 89. Latin America Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Nitazoxanide Drug Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Nitazoxanide Drug Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Nitazoxanide Drug Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Nitazoxanide Drug Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Nitazoxanide Drug Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Nitazoxanide Drug Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Nitazoxanide Drug Sales by Application (2016-2021) & (K Units)
Table 98. Middle East and Africa Nitazoxanide Drug Sales by Application (2022-2027) & (K Units)
Table 99. Middle East and Africa Nitazoxanide Drug Revenue by Application (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Nitazoxanide Drug Revenue by Application (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Nitazoxanide Drug Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Nitazoxanide Drug Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Nitazoxanide Drug Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Nitazoxanide Drug Revenue by Country (2022-2027) & (US$ Million)
Table 105. Romark Laboratories Corporation Information
Table 106. Romark Laboratories Description and Major Businesses
Table 107. Romark Laboratories Nitazoxanide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Romark Laboratories Nitazoxanide Drug Product
Table 109. Romark Laboratories Recent Developments
Table 110. Chugai Pharmaceutical Corporation Information
Table 111. Chugai Pharmaceutical Description and Major Businesses
Table 112. Chugai Pharmaceutical Nitazoxanide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Chugai Pharmaceutical Nitazoxanide Drug Product
Table 114. Chugai Pharmaceutical Recent Developments
Table 115. Lupin Corporation Information
Table 116. Lupin Description and Major Businesses
Table 117. Lupin Nitazoxanide Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Lupin Nitazoxanide Drug Product
Table 119. Lupin Recent Developments
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Nitazoxanide Drug Distributors List
Table 123. Nitazoxanide Drug Customers List
Table 124. Nitazoxanide Drug Market Trends
Table 125. Nitazoxanide Drug Market Drivers
Table 126. Nitazoxanide Drug Market Challenges
Table 127. Nitazoxanide Drug Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Nitazoxanide Drug Product Picture
Figure 2. Global Nitazoxanide Drug Market Share by Type in 2020 & 2027
Figure 3. Tablets Product Picture
Figure 4. Oral Suspension Product Picture
Figure 5. Global Nitazoxanide Drug Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Retail Pharmacy
Figure 8. Other
Figure 9. Nitazoxanide Drug Report Years Considered
Figure 10. Global Nitazoxanide Drug Sales 2016-2027 (K Units)
Figure 11. Global Nitazoxanide Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Nitazoxanide Drug Revenue 2016-2027 (US$ Million)
Figure 13. Global Nitazoxanide Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Nitazoxanide Drug Sales Market Share by Region (2016-2021)
Figure 15. Global Nitazoxanide Drug Sales Market Share by Region (2022-2027)
Figure 16. North America Nitazoxanide Drug Sales YoY (2016-2027) & (K Units)
Figure 17. North America Nitazoxanide Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Nitazoxanide Drug Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Nitazoxanide Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Nitazoxanide Drug Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Nitazoxanide Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Nitazoxanide Drug Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Nitazoxanide Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Nitazoxanide Drug Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Nitazoxanide Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Nitazoxanide Drug Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Nitazoxanide Drug Revenue in 2020
Figure 28. Nitazoxanide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Nitazoxanide Drug Sales Market Share by Type (2016-2027)
Figure 30. Global Nitazoxanide Drug Revenue Market Share by Type (2016-2027)
Figure 31. Global Nitazoxanide Drug Sales Market Share by Application (2016-2027)
Figure 32. Global Nitazoxanide Drug Revenue Market Share by Application (2016-2027)
Figure 33. North America Nitazoxanide Drug Sales Market Share by Type (2016-2027)
Figure 34. North America Nitazoxanide Drug Revenue Market Share by Type (2016-2027)
Figure 35. North America Nitazoxanide Drug Sales Market Share by Application (2016-2027)
Figure 36. North America Nitazoxanide Drug Revenue Market Share by Application (2016-2027)
Figure 37. North America Nitazoxanide Drug Sales Share by Country (2016-2027)
Figure 38. North America Nitazoxanide Drug Revenue Share by Country (2016-2027)
Figure 39. United States Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Nitazoxanide Drug Sales Market Share by Type (2016-2027)
Figure 42. Europe Nitazoxanide Drug Revenue Market Share by Type (2016-2027)
Figure 43. Europe Nitazoxanide Drug Sales Market Share by Application (2016-2027)
Figure 44. Europe Nitazoxanide Drug Revenue Market Share by Application (2016-2027)
Figure 45. Europe Nitazoxanide Drug Sales Share by Country (2016-2027)
Figure 46. Europe Nitazoxanide Drug Revenue Share by Country (2016-2027)
Figure 47. Germany Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 48. France Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Nitazoxanide Drug Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Nitazoxanide Drug Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Nitazoxanide Drug Sales Market Share by Application (2016-2027)
Figure 55. Asia Pacific Nitazoxanide Drug Revenue Market Share by Application (2016-2027)
Figure 56. Asia Pacific Nitazoxanide Drug Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Nitazoxanide Drug Revenue Share by Region (2016-2027)
Figure 58. China Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 61. India Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Nitazoxanide Drug Sales Market Share by Type (2016-2027)
Figure 68. Latin America Nitazoxanide Drug Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Nitazoxanide Drug Sales Market Share by Application (2016-2027)
Figure 70. Latin America Nitazoxanide Drug Revenue Market Share by Application (2016-2027)
Figure 71. Latin America Nitazoxanide Drug Sales Share by Country (2016-2027)
Figure 72. Latin America Nitazoxanide Drug Revenue Share by Country (2016-2027)
Figure 73. Mexico Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Nitazoxanide Drug Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Nitazoxanide Drug Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Nitazoxanide Drug Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Nitazoxanide Drug Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Nitazoxanide Drug Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Nitazoxanide Drug Revenue Share by Country (2016-2027)
Figure 83. Turkey Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Nitazoxanide Drug Revenue (2016-2027) & (US$ Million)
Figure 86. Nitazoxanide Drug Value Chain
Figure 87. Nitazoxanide Drug Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---